The elution of poly (vinyl alcohol) from a contact lens: The realization of a time release moisturizing agent/artificial tear

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 80, Issue 2, 2007, Pages 424-432

  Winterton, Lynn C ^a   Lally, John M ^a   Sentell, Karen B ^a   Chapoy, L Lawrence ^b  

^a CIBA Vision Corporation   (United States)

^b HPM Company   (United States)

Author keywords

Artificial tears; Contact lens; Delivery vehicle; Drug elution; Ocular delivery; Time release

Indexed keywords

ARTIFICIAL TEARS; DELIVERY VEHICLE; DRUG DELIVERY; DRUG ELUTION; OCULAR DELIVERY; TIME RELEASE;

CONTACT LENSES; CONTROLLED DRUG DELIVERY; CROSSLINKING; DRUG DOSAGE; HYDROGELS; MONOMERS; POLYMERIZATION;

POLYVINYL ALCOHOLS;

ARTIFICIAL TEAR; MONOMER; NELFILCON A; POLYMER; POLYVINYL ALCOHOL; UNCLASSIFIED DRUG;

ARTICLE; CONTACT LENS; CROSS LINKING; DEVICE; DRUG DELIVERY SYSTEM; ELUTION; HYDROGEL; IN VITRO STUDY; IN VIVO STUDY; MODEL; MOLECULAR WEIGHT; POLYMERIZATION;

BIOCOMPATIBLE MATERIALS; CONTACT LENSES, HYDROPHILIC; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; HUMANS; HYDROGELS; MATERIALS TESTING; OPHTHALMIC SOLUTIONS; POLYVINYL ALCOHOL; PROSPECTIVE STUDIES;

EID: 33846956791     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.30613     Document Type: Article

References (36)

1. Gulsen D, Chauban A. Ophthalmic drug delivery through contact lenses. IOVS 2004;45:2342-2347.
2. Karpecki PM. Special delivery: Alternative to drops. Rev Optometry 2003;140(8).
3. Fischer G, Parkinson TM, Szlek MA. OcuPhor - The future of ocular drug delivery. Drug Delivery Technol 2002;2:50-55.
4. Le Bourlais C, Acar L, Zia H, Sado PA, Needham T, Leverge R. Ophthalmic drug delivery systems - Recent advances. Prog Retinal Eye Res 1998;17:33-58
5. Prevo M. Progestasert and Ocusert therapeutic system technologies. In: Salem H, Baskin SI, editors. New Technologies and Concepts for Reducing Drug Toxicities, Vol. 6, Cleveland, Ohio: CRC Press; 1992.
6. Gabler B, Fuchs B, Herrmann W, Winkler von Mohrenfels C, Kölwel C, Wiegrebe E, Göpferich A, Lohman C. EGF supplement therapy with a controlled release device in patients with keratoconjunctivitis sicca seems to improve dry eye symptoms, in abstracts ARVO 2004, ARVO Annual Meeting Abstracts 2004, Fort Lauderdale, FL.
7. Guo H, Ashton, P. Method for treating and/or preventing retinal diseases with sustained release corticosteroids. US Patent Application Publication: US 2004 0121014 A1.
8. Park J, Melhem M, Pankaj D, Millard RW, Banerjee RK. Controlled drug releasing intravitreal implant using biodegradable PLGA. Am Soc Mech Eng, Bioeng Div (BED) 2003;55:11-12.
9. Kramer MD. PDA's office of combination products: Roles, progress & challenges. J Med Device Regul 2005;2:3.
10. Office of Combination Products. http://www.fda.gov/oc/combination. 2 Feb 2006.
11. Ophthalmic demulcents. paragraph 349.12 subheading of ophthalmic drug products for over-the-counter human in Code of Federal Regulations 21 CFR Ch 1, 4-1-2001 edition.
12. Farris RL. Contact lenses and the dry eye. Int Ophthalmol Clin 1994;34:129-136.
13. Smith RE. The tear film complex: Pathogenesis and emerging therapies for dry eyes. Cornea 2005;24:1-7.
14. Morris S, Davis JE. Relief for contact lens-related dry eye. Contact Lens Spectrum 2006; January:42-43.
15. Paugh JR. Managing contact lens-related dry eye. Contact Lens Spectrum 2005; Sep:32-36.
16. Müller B. Photocrosslinked polymers, US Patent 5,583,163,1996.
17. Müller B. Photocrosslinkable materials and applications, US Patent 6,407,145,2002.
18. Mühlebach A, Müller B, Pharisa C, Hofmann H, Seiferling B, Guerry G. New water-soluble photo crosslinkable polymers based upon modified poly (vinyl alcohol). J Polym Sci Part A: Polym Chem 1997;35:3603-3611.
19. Müller B. Photocrosslinked polymers, US Patent 5,508,317,1996.
20. Müller B. Photocrosslinked polymers, US Patent 5,789,464,1998.
21. Müller B. Photocrosslinked polymers, US Patent 5,849,810,1998.
22. Bühler N, Haerri HP, Hofman M, Irrgang C, Mühlebach A, Müller B, Stockinger F. Nelfilcon A, a new material for contact lenses. Chimia 1999;53:269.
23. Hough T. Technology leaps light years ahead. Optician 1997; 214:16-18
24. Mahomed A, Ross G, Tighe B. Contact lenses and comfort enhancers: In vivo and in vitro release of soluble PVA. Presented at the British Contact Lens Association's Clinical Conference, Birmingham, England, May 21-23, 2004.
25. Maissa C, Tonge S, Guillon M, Tighe B. Surface properties of daily disposable contact lenses. Contact lens & ant. Eye 1998; 21:138.
26. Measuring principles of KRÜSS tensiometers. http://www. kruss.info 1 Feb 2006
27. FDA Premarket notification (510(k)) guidance document for daily wear contact lenses, May 1994. (see also http://www. fda.gov/cdrh/ode/conta.html).
28. International Standards Organization (ISO) - Test methods for the determination of shelf life of contact lenses, optics and optical instruments 11987,1997.
29. Nilsson SEG. Ten years of disposable contact lenses - A review of benefits and risks. Contact Lens Anterior Eye 1997;20:119-128.
30. Inamura I. Liquid-liquid separation and gelation in the poly (vinyl alcohol)-Poly(ethylene glycol)-water system. Dependence on molecular weight of poly(ethylene glycol). Polym J 1986;18:269-272.
31. Keterson HA, Meadows DM, McQueen ND, Stone RP. Wettability of silicone hydrogels lenses in the presence of tear components. Review of cornea and contact lenses April 2005;44:24-28.
32. Holly FJ. Ophthalmic solution for treatment of dry-eye syndrome. US Patent 4,883,658,1989.
33. Holly FJ. Ophthalmic solution for treatment of dry eye syndrome. US Patent 4,744,980,1988.
34. Nick J, Winterton L, Lally J. Enhancing comfort with a lubricating daily disposable. Optician 2005;6004:30-32.
35. Hehl EM, Beck R, Luthard K, Guthoff R, Drewelow B. Improved penetration of aminoglycosides and fluoroquinolones into the aqueous humour of patients by means of Acuvue contact lenses. Eur J Clin Pharmacol 1999;55:317-323.
36. Schnider C, Steffen R. A next-generation silicone hydrogel lens for daily wear: Part 2. Clinical performance. Optician 2004;228:20-24.